CD4+ T-cell help amplifies innate signals for primary CD8+ T-cell immunity

Immunological Reviews

Volumn 272, Issue 1, 2016, Pages 52-64

  Bedoui, Sammy ^a   Heath, William R ^a   Mueller, Scott N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

cell activation; costimulation, CD40; cytotoxic T cells; dendritic cells; helper T cells

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CARBON TETRACHLORIDE; CD40 ANTIGEN; CD40 LIGAND; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 15; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR 3;

ANTIGEN PRESENTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL INTERACTION; CELL MIGRATION; CELLULAR IMMUNITY; DENDRITIC CELL; HERPES SIMPLEX; HUMAN; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN; SKIN INFECTION;

EID: 84975480271     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12426     Document Type: Review

References (107)

1. Williams MA, Bevan MJ. Effector and memory CTL differentiation. Annu Rev Immunol 2007;25:171–192.
2. Mora JR, von Andrian UH. Retinoic acid: an educational “vitamin elixir” for gut-seeking T cells. Immunity 2004;21:458–460.
3. + T cells. Nature 2011;477:216–219.
4. Heath WR, Carbone FR. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol 2009;10:1237–1244.
5. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013;31:563–604.
6. + dendritic cell subset. Immunol Rev 2010;234:18–31.
7. Villadangos JA, Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 2007;7:543–555.
8. Luber CA, et al. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 2010;32:279–289.
9. Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 2006;6:476–483.
10. Satpathy AT, Wu X, Albring JC, Murphy KM. Re(de)fining the dendritic cell lineage. Nat Immunol 2012;13:1145–1154.
11. Reizis B. Classical dendritic cells as a unique immune cell lineage. J Exp Med 2012;209:1053–1056.
12. Neyt K, Lambrecht BN. The role of lung dendritic cell subsets in immunity to respiratory viruses. Immunol Rev 2013;255:57–67.
13. Malissen B, Tamoutounour S, Henri S. The origins and functions of dendritic cells and macrophages in the skin. Nat Rev Immunol 2014;14:417–428.
14. Kaplan DH. Langerhans cells: not your average dendritic cell. Trends Immunol 2010;31:437.
15. + dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 2010;207:189–206.
16. Platt AM, Randolph GJ. Dendritic cell migration through the lymphatic vasculature to lymph nodes. Adv Immunol 2013;120:51–68.
17. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007;7:19–30.
18. Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 2008;8:935–947.
19. + dendritic cells. J Exp Med 2010;207:1273–1281.
20. Crozat K, et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J Exp Med 2010;207:1283–1292.
21. Belz GT, Nutt SL. Transcriptional programming of the dendritic cell network. Nat Rev Immunol 2012;12:101–113.
22. + dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci USA 2006;103:10729–10734.
23. Dudziak D, et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007;315:107–111.
24. Nair-Gupta P, Blander JM. An updated view of the intracellular mechanisms regulating cross-presentation. Front Immunol 2013;4:401.
25. Kurts C, Robinson BW, Knolle PA. Cross-priming in health and disease. Nat Rev Immunol 2010;10:403–414.
26. Joffre OP, Segura E, Savina A, Amigorena S. Cross-presentation by dendritic cells. Nat Rev Immunol 2012;12:557–569.
27. Ackerman AL, Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat Immunol 2004;5:678–684.
28. Swiecki M, Colonna M. The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol 2015;15:471–485.
29. Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008;8:594–606.
30. Villadangos JA, Young L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 2008;29:352–361.
31. Plantinga M, et al. Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 2013;38:322–335.
32. + T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J Immunol 2004;172:392–397.
33. Jenkins MK, Chu HH, McLachlan JB, Moon JJ. On the composition of the preimmune repertoire of T cells specific for Peptide-major histocompatibility complex ligands. Annu Rev Immunol 2010;28:275–294.
34. Allan RS, et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006;25:153–162.
35. + dendritic cells. Nat Immunol 2009;10:488–495.
36. Eidsmo L, Allan R, Caminschi I, van Rooijen N, Heath WR, Carbone FR. Differential migration of epidermal and dermal dendritic cells during skin infection. J Immunol 2009;182:3165–3172.
37. Mueller SN, Heath W, McLain JD, Carbone FR, Jones CM. Characterization of two TCR transgenic mouse lines specific for herpes simplex virus. Immunol Cell Biol 2002;80:156–163.
38. Allan RS, et al. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 2003;301:1925–1928.
39. Clausen BE, Stoitzner P. Functional specialization of skin dendritic cell subsets in regulating T cell responses. Front Immunol 2015;6:534.
40. Carbone FR, Belz GT, Heath WR. Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity. Trends Immunol 2004;25:655–658.
41. + dendritic cells. Immunol Rev 2010;234:268–281.
42. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009;9:581–593.
43. Zaccard CR, et al. CD40L induces functional tunneling nanotube networks exclusively in dendritic cells programmed by mediators of type 1 immunity. J Immunol 2015;194:1047–1056.
44. Saccheri F, et al. Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity. Sci Transl Med 2010;2:44ra57.
45. Mazzini E, Massimiliano L, Penna G, Rescigno M. Oral tolerance can be established via gap junction transfer of fed antigens from CX3CR1(+) macrophages to CD103(+) dendritic cells. Immunity 2014;40:248–261.
46. Bedoui S, Greyer M. The role of dendritic cells in immunity against primary herpes simplex virus infections. Front Microbiol 2014;5:533.
47. Piguet V. Receptor modulation in viral replication: HIV, HSV, HHV-8 and HPV: same goal, different techniques to interfere with MHC-I antigen presentation. Curr Top Microbiol Immunol 2005;285:199–217.
48. Suazo PA, et al. Evasion of early antiviral responses by herpes simplex viruses. Mediators Inflamm 2015;2015:593757.
49. Davis MM, Krogsgaard M, Huse M, Huppa J, Lillemeier BF, Li QJ. T cells as a self-referential, sensory organ. Annu Rev Immunol 2007;25:681–695.
50. + T cell activation to localized viral infection. Immunity 2015;43:554–565.
51. Davey GM, Wojtasiak M, Proietto AI, Carbone FR, Heath WR, Bedoui S. Cutting edge: priming of CD8 T cell immunity to herpes simplex virus type 1 requires cognate TLR3 expression in vivo. J Immunol 2010;184:2243–2246.
52. Paludan SR, Bowie AG. Immune sensing of DNA. Immunity 2013;38:870–880.
53. Parker ZM, Murphy AA, Leib DA. Role of the DNA sensor STING in protection from lethal infection following corneal and intracerebral challenge with herpes simplex virus 1. J Virol 2015;89:11080–11091.
54. Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009;461:788–792.
55. Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol 2011;12:959–965.
56. Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013;339:786–791.
57. Wu J, et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 2013;339:826–830.
58. Unterholzner L, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010;11:997–1004.
59. Perales-Linares R, Navas-Martin S. Toll-like receptor 3 in viral pathogenesis: friend or foe? Immunology 2013;140:153–167.
60. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 2006;80:5059–5064.
61. Atianand MK, Fitzgerald KA. Long non-coding RNAs and control of gene expression in the immune system. Trends Mol Med 2014;20:623–631.
62. Schulz O, et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 2005;433:887–892.
63. Zhang SY, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007;317:1522–1527.
64. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998;393:480–483.
65. + T-helper and a T-killer cell. Nature 1998;393:474–478.
66. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998;393:478–480.
67. + T cells: when, where, and how. Annu Rev Immunol 2006;24:519–540.
68. Bevan MJ. Helping the CD8(+) T-cell response. Nat Rev Immunol 2004;4:595–602.
69. Liu D, et al. T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction. Nature 2015;517:214–218.
70. Smith CM, et al. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity. Nat Immunol 2004;5:1143–1148.
71. + T cell memory. Science 2002;297:2060–2063.
72. Johnson S, et al. Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells. Immunity 2009;30:218–227.
73. Greyer M, et al. T cell help amplifies innate signals in CD8 DCs for optimal CD8 T cell priming. Cell Rep 2016;14:586–597.
74. Wiesel M, Kratky W, Oxenius A. Type I IFN substitutes for T cell help during viral infections. J Immunol 2011;186:754–763.
75. + T cells following infection with herpes simplex virus type 1. J Virol 2009;83:5256–5268.
76. Wiesel M, Oxenius A. From crucial to negligible: functional CD8(+) T-cell responses and their dependence on CD4(+) T-cell help. Eur J Immunol 2012;42:1080–1088.
77. Filatenkov AA, Jacovetty EL, Fischer UB, Curtsinger JM, Mescher MF, Ingulli E. CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of tolerance. J Immunol 2005;174:6909–6917.
78. + T cell longevity and avoidance of TRAIL-mediated apoptosis. Proc Natl Acad Sci USA 2008;105:5201–5206.
79. Schulz O, et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000;13:453–462.
80. + T cell-dendritic cell interaction. Nature 2006;440:890–895.
81. Macagno A, Napolitani G, Lanzavecchia A, Sallusto F. Duration, combination and timing: the signal integration model of dendritic cell activation. Trends Immunol 2007;28:227–233.
82. Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 2005;6:769–776.
83. Crawford A, Angelosanto JM, Nadwodny KL, Blackburn SD, Wherry EJ. A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection. PLoS Pathog 2011;7:e1002098.
84. + T cells. J Immunol 2007;178:778–787.
85. Swiecki M, Wang Y, Gilfillan S, Colonna M. Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections. PLoS Pathog 2013;9:e1003728.
86. Yatim N, et al. RIPK1 and NF-kappaB signaling in dying cells determines cross-priming of CD8(+) T cells. Science 2015;350:328–334.
87. Mempel TR, Henrickson SE, Von Andrian UH. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 2004;427:154–159.
88. Mitchison NA, O'Malley C. Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response. Eur J Immunol 1987;17:1579–1583.
89. Keene JA, Forman J. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med 1982;155:768–782.
90. + T cell help. J Exp Med 1997;186:65–70.
91. Eickhoff S, et al. Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions. Cell 2015;162:1322–1337.
92. Kitano M, et al. Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node. Proc Natl Acad Sci USA 2016;113:1044–1049.
93. Lee HK, et al. Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J Exp Med 2009;206:359–370.
94. + dendritic cells are protected from influenza virus infection. J Clin Invest 2012;122:4037–4047.
95. Nakanishi Y, Lu B, Gerard C, Iwasaki A. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 2009;462:510–513.
96. + T cells during influenza viral infection. Immunity 2014;41:633–645.
97. Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 2006;6:595–601.
98. + T cells in primary and secondary responses. Proc Natl Acad Sci USA 2010;107:193–198.
99. Feau S, Arens R, Togher S, Schoenberger SP. Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells. Nat Immunol 2011;12:908–913.
100. + T cells by maximizing autocrine IL-2/IL-2 receptor signaling. PLoS ONE 2015;10:e0126765.
101. Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol 2005;17:275–281.
102. + T cells. Nat Immunol 2007;8:1060–1066.
103. Willoughby JE, et al. Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunization. J Immunol 2014;193:244–251.
104. Feau S, Garcia Z, Arens R, Yagita H, Borst J, Schoenberger SP. The CD4(+) T-cell help signal is transmitted from APC to CD8(+) T-cells via CD27-CD70 interactions. Nat Commun 2012;3:948.
105. + regulatory T cells. J Immunol 2007;178:280–290.
106. + memory T cells. Nature 2006;441:890–893.
107. + T cells after acute infection. Nat Immunol 2004;5:927–933.